175 related articles for article (PubMed ID: 35972650)
21. Antimicrobial and antibiofilm activities of ursolic acid against carbapenem-resistant Klebsiella pneumoniae.
Qian W; Wang W; Zhang J; Wang T; Liu M; Yang M; Sun Z; Li X; Li Y
J Antibiot (Tokyo); 2020 Jun; 73(6):382-391. PubMed ID: 32051569
[TBL] [Abstract][Full Text] [Related]
22. Antifungal activity of peptide MSI-1 against Cryptococcus neoformans infection in vitro and in murine cryptococcal meningoencephalitis.
Ma L; Wei S; Ye X; Xu P; Chen H; Liu Z; Zhou C
Peptides; 2020 Aug; 130():170334. PubMed ID: 32504765
[TBL] [Abstract][Full Text] [Related]
23. Miltefosine Has a Postantifungal Effect and Induces Apoptosis in Cryptococcus Yeasts.
Spadari CC; Vila T; Rozental S; Ishida K
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844051
[No Abstract] [Full Text] [Related]
24. Antifolates inhibit Cryptococcus biofilms and enhance susceptibility of planktonic cells to amphotericin B.
de Aguiar Cordeiro R; Mourão CI; Rocha MF; de Farias Marques FJ; Teixeira CE; de Oliveira Miranda DF; Neto LV; Brilhante RS; de Jesus Pinheiro Gomes Bandeira T; Sidrim JJ
Eur J Clin Microbiol Infect Dis; 2013 Apr; 32(4):557-64. PubMed ID: 23192488
[TBL] [Abstract][Full Text] [Related]
25. Anti-Cryptococcal activity of a furanone derivative-antibiofilm and opsonophagocytic potential.
Rathore SS; Raman T; Lalitha C; Ramar M; Munusamy A; Ramakrishnan J
J Mycol Med; 2020 Jun; 30(2):100924. PubMed ID: 32037102
[TBL] [Abstract][Full Text] [Related]
26. Blap-6, a Novel Antifungal Peptide from the Chinese Medicinal Beetle
Zhang LM; Zhou SW; Huang XS; Chen YF; Mwangi J; Fang YQ; Du T; Zhao M; Shi L; Lu QM
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791374
[No Abstract] [Full Text] [Related]
27. A potential of propolis on major virulence factors of Cryptococcus neoformans.
Thammasit P; Iadnut A; Mamoon K; Khacha-Ananda S; Chupradit K; Tayapiwatana C; Kasinrerk W; Tragoolpua Y; Tragoolpua K
Microb Pathog; 2018 Oct; 123():296-303. PubMed ID: 30041002
[TBL] [Abstract][Full Text] [Related]
28. Discovery of Simplified Sampangine Derivatives with Potent Antifungal Activities against Cryptococcal Meningitis.
Li Z; Liu N; Tu J; Ji C; Han G; Sheng C
ACS Infect Dis; 2019 Aug; 5(8):1376-1384. PubMed ID: 31070884
[TBL] [Abstract][Full Text] [Related]
29. Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin.
van Duin D; Casadevall A; Nosanchuk JD
Antimicrob Agents Chemother; 2002 Nov; 46(11):3394-400. PubMed ID: 12384341
[TBL] [Abstract][Full Text] [Related]
30. Darunavir inhibits
Brilhante RSN; Silva JAT; Araújo GDS; Pereira VS; Gotay WJP; Oliveira JS; Guedes GMM; Pereira-Neto WA; Castelo-Branco DSCM; Cordeiro RA; Sidrim JJC; Rocha MFG
J Med Microbiol; 2020 Jun; 69(6):830-837. PubMed ID: 32459616
[No Abstract] [Full Text] [Related]
31. Investigation of the antifungal activity of carvacrol against strains of Cryptococcus neoformans.
Nóbrega RO; Teixeira AP; Oliveira WA; Lima EO; Lima IO
Pharm Biol; 2016 Nov; 54(11):2591-2596. PubMed ID: 27225838
[TBL] [Abstract][Full Text] [Related]
32. New Triazole NT-a9 Has Potent Antifungal Efficacy against Cryptococcus neoformans
Lu RY; Ni TJ; Wu J; Yan L; Lv QZ; Li LP; Zhang DZ; Jiang YY
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31791946
[TBL] [Abstract][Full Text] [Related]
33. Calcimycin Inhibits
Tharappel AM; Li Z; Zhu YC; Wu X; Chaturvedi S; Zhang QY; Li H
ACS Infect Dis; 2022 Sep; 8(9):1851-1868. PubMed ID: 35948057
[TBL] [Abstract][Full Text] [Related]
34. Heterocycle Thiazole Compounds Exhibit Antifungal Activity through Increase in the Production of Reactive Oxygen Species in the Cryptococcus neoformans-Cryptococcus gattii Species Complex.
Sá NP; Lima CM; Lino CI; Barbeira PJS; Baltazar LM; Santos DA; Oliveira RB; Mylonakis E; Fuchs BB; Johann S
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533240
[TBL] [Abstract][Full Text] [Related]
35. Antifungal susceptibility testing with YeastONE™ is not predictive of clinical outcomes of Cryptococcus neoformans var. grubii fungemia.
Yang JH; Huang PY; Cheng CW; Shie SS; Lin ZF; Yang LY; Lee CH; Wu TS
Med Mycol; 2021 Nov; 59(11):1114-1121. PubMed ID: 34374784
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans.
Teymuri M; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
Bioorg Med Chem Lett; 2021 Jun; 41():128013. PubMed ID: 33811994
[TBL] [Abstract][Full Text] [Related]
37. [Melanin and its role on the virulence of Cryptococcus neoformans].
Alp S
Mikrobiyol Bul; 2010 Jul; 44(3):519-26. PubMed ID: 21064003
[TBL] [Abstract][Full Text] [Related]
38. Repurposing the thrombopoietin receptor agonist eltrombopag as an anticryptococcal agent.
Ko HT; Hsu LH; Yang SY; Chen YL
Med Mycol; 2020 Jun; 58(4):493-504. PubMed ID: 31297540
[TBL] [Abstract][Full Text] [Related]
39. A Highly Active Triterpene Derivative Capable |of Biofilm Damage to Control
Krummenauer ME; Lopes W; Garcia AWA; Schrank A; Gnoatto SCB; Kawano DF; Vainstein MH
Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31817559
[No Abstract] [Full Text] [Related]
40. Antifungal activity study of the monoterpene thymol against
Teixeira APC; Nóbrega RO; Lima EO; Araújo WO; Lima IO
Nat Prod Res; 2020 Sep; 34(18):2630-2633. PubMed ID: 30584769
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
